Every US drug recall in the openFDA Enforcement database, analysed by year, by FDA class (how serious), by why the drug was recalled, and by manufacturer — plus how fast the system responds and who starts the recall.
Read the analysis →Datasets
Original analyses built on the FDA’s own public records. Each one is a readable study and a downloadable CSV, cites its openFDA source, and is free to reuse with attribution to pharmaranks. We are a ratings authority, not a seller — so these are the numbers as the regulator publishes them, not a pitch.
The recalls caused by contamination or impurity, split into the kinds people distinguish: microbial and sterility failures, foreign particulate, chemical degradants, and the nitrosamine impurities behind the valsartan, metformin and ranitidine recalls — with the Class I share of each.
Read the analysis →How much of the prescription market is no longer sold, computed from the Drugs@FDA marketing-status field — which drug classes churn fastest as generics replace older versions, and which endure.
Read the analysis →Source data: the openFDA drug Enforcement and Drugs@FDA databases, published by the U.S. Food and Drug Administration. Figures are recall or product events, not units, and reflect the public record at the time of each study’s last update. This is public regulatory data, not medical advice.